Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial

Thomas Powles, Michael B. Atkins, Bernard Escudier, Robert J. Motzer, Brian I. Rini, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, Mario Sznol, John D. Hainsworth, Walter M. Stadler, Thomas E. Hutson, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Toni K. Choueiri, James A. Reeves, Allen Lee Cohn, Beiying Ding, Ning Leng, Kenji Hashimoto, Mahrukh Huseni, Christina Schiff, David F. McDermott